[HTML][HTML] Lipid alterations in chronic liver disease and liver cancer

B Paul, M Lewinska, JB Andersen - JHEP reports, 2022 - Elsevier
Lipids are a complex and diverse group of molecules with crucial roles in many
physiological processes, as well as in the onset, progression, and maintenance of cancers …

The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism

LY Tian, DJ Smit, M Jücker - International Journal of Molecular Sciences, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in
the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains …

CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis

P Yang, H Qin, Y Li, A Xiao, E Zheng, H Zeng… - Nature …, 2022 - nature.com
Liver metastasis is highly aggressive and treatment-refractory, partly due to macrophage-
mediated immune suppression. Understanding the mechanisms leading to functional …

[HTML][HTML] Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges

MDA Paskeh, F Ghadyani, M Hashemi… - Pharmacological …, 2023 - Elsevier
Cancer progression results from activation of various signaling networks. Among these,
PI3K/Akt signaling contributes to proliferation, invasion, and inhibition of apoptosis …

CD36 favours fat sensing and transport to govern lipid metabolism

Y Li, X Huang, G Yang, K Xu, Y Yin, G Brecchia… - Progress in lipid …, 2022 - Elsevier
CD36, located on the cell membrane, transports fatty acids in response to dietary fat. It is a
critical fatty acid sensor and regulator of lipid metabolism. The interaction between CD36 …

The role of CD36 in cancer progression and its value as a therapeutic target

WW Feng, HT Zuppe, M Kurokawa - Cells, 2023 - mdpi.com
Cluster of differentiation 36 (CD36) is a cell surface scavenger receptor that plays critical
roles in many different types of cancer, notably breast, brain, and ovarian cancers. While it is …

Role of CD36 in cancer progression, stemness, and targeting

SL Guerrero-Rodríguez, C Mata-Cruz… - Frontiers in Cell and …, 2022 - frontiersin.org
CD36 is highly expressed in diverse tumor types and its expression correlates with
advanced stages, poor prognosis, and reduced survival. In cancer cells, CD36: 1) increases …

Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway

C Wang, Z Yang, E Xu, X Shen, X Wang… - Clinical and …, 2021 - Wiley Online Library
Background Peritoneal metastasis (PM) occurs frequently in patients with gastric cancer
(GC) and confers poor survival. Lipid metabolism acts as a non‐negligible regulator in …

SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity

F Wang, Y Gao, S Xue, L Zhao, H Jiang… - Nature …, 2023 - nature.com
CSCs (Cancer stem cells) with distinct metabolic features are considered to cause HCC
(hepatocellular carcinoma) initiation, metastasis and therapeutic resistance. Here, we …

CD36: an emerging therapeutic target for cancer and its molecular mechanisms

C Ruan, Y Meng, H Song - Journal of Cancer Research and Clinical …, 2022 - Springer
Tumor cells need to rewire their metabolic pathways to regulate the nutrient uptake and
metabolism to sustain the energy production. Lipids are important components of energy …